Strain in Microbacterium and method for producing psicose using same

US11859226B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11859226-B2
Application numberUS-201716603213-A
CountryUS
Kind codeB2
Filing dateDec 26, 2017
Priority dateJun 2, 2017
Publication dateJan 2, 2024
Grant dateJan 2, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a newly isolated bacterium belonging to the genus Microbacterium , a composition for producing psicose comprising the strain, and a method for producing psicose using the same.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a psicose from a fructose-containing substrate using a bacterium belonging to the genus Microbacterium having a psicose conversion activity, comprising reacting the fructose-containing substrate with at least one selected from the group consisting of a microbial cell of the bacterium, a culture of the bacterium, and a lysate of the bacterium in the presence of at least one metal ion selected from the group consisting of manganese ion and cobalt ion, wherein the bacterium belonging to the genus Microbacterium is Microbacterium phyllosphaerae, wherein the Microbacterium phyllosphaerae is a strain deposited as an accession number KCCM12034P. 2. The method for producing a psicose of claim 1 , wherein the step of reacting is performed by contacting the fructose-containing substrate with a support immobilized with at least one selected from the group consisting of a microbial cell of the bacterium, a culture of the bacterium, and a lysate of the bacterium. 3. The method for producing a psicose of claim 1 , wherein the fructose-containing substrate contains fructose at a concentration of 40 to 75% (w/w). 4. The method for producing a psicose of claim 1 , wherein the method is characterized by not using a buffer solution. 5. The method for producing a psicose of claim 1 , wherein the method is performed under the temperature condition of 40 to 80° C. 6. The method for producing a psicose of claim 1 , wherein the method is performed for 1 to 48 hours.

Assignees

Inventors

Classifications

  • C12P1/02Primary

    by using fungi · CPC title

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

  • Bacterial isolates · CPC title

  • Mycobacterium · CPC title

  • C12P19/02Primary

    Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11859226B2 cover?
The present invention relates to a newly isolated bacterium belonging to the genus Microbacterium , a composition for producing psicose comprising the strain, and a method for producing psicose using the same.
Who is the assignee on this patent?
Samyang Corp
What technology area does this patent fall under?
Primary CPC classification C12P1/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).